Neovascular Age-Related Macular Degeneration: Potential Therapies

Author： Chappelow Aimee V.   Kaiser Peter K.  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.68, Iss.8, 2008-01, pp. : 1029-1036

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An update on the pharmacotherapy of neovascular age-related macular degeneration

By Freund K Bailey   Mrejen Sarah   Gallego-Pinazo Roberto  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 8, 2013-06 ,pp. : 1017-1028

Informa Healthcare

Access to resources Recommend Favorite

Current and future therapies for age-related macular degeneration

By Beutel Julia   Rudolf Martin   Grisanti Salvatore  

Expert Opinion on Emerging Drugs, Vol. 14, Iss. 2, 2009-06 ,pp. : 341-362

Informa Healthcare

Access to resources Recommend Favorite

Age-related macular degeneration therapies eyed up

By  

Inpharma, Vol. 1, Iss. 1365, 2002-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

New therapies for the treatment of age-related macular degeneration

By Sarrafizadeh R.   Trese M.T.  

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 3, 2000-03 ,pp. : 333-341

Informa Healthcare

Access to resources Recommend Favorite

Intravitreal aflibercept injection for neovascular (wet) age-related macular degeneration

By Ohr Matthew   Kaiser Peter K  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 4, 2012-03 ,pp. : 585-591

Informa Healthcare

Access to resources Recommend Favorite